Symbolbild · KI-generiert
Principal Technologies Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Principal Technologies Inc. is a Canadian-based healthcare technologies acquisition company. The Company is engaged in building a global portfolio of profitable healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Principal Technologies Inc. | PTEC | TSXV | 13 Mio. USD |
| MedX Health Corp. | MDX | TSXV | 13 Mio. USD |
| Nanalysis Scientific Corp. | NSCI | TSXV | 12 Mio. USD |
| Izotropic Corporation | IZO | CSE | 12 Mio. USD |
| Pharmala Biotech Holdings Inc. | MDMA | CSE | 12 Mio. USD |
| KDA Group Inc. | KDA | TSXV | 12 Mio. USD |
| Avicanna Inc. | AVCN | TSX | 12 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.